A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
Authors
Keywords
Thyroid carcinomas, Cancer treatment, Apoptosis, Cyclins, Cell cycle and cell division, Prophase, Mitosis, Cell cycle inhibitors
Journal
PLoS One
Volume 12, Issue 2, Pages e0172315
Publisher
Public Library of Science (PLoS)
Online
2017-02-17
DOI
10.1371/journal.pone.0172315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
- (2015) Xiu-Xiu Chen et al. Oncotarget
- Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
- (2014) S. K. Kumar et al. BLOOD
- Cdk5 regulates multiple cellular events in neural development, function and disease
- (2014) Takeshi Kawauchi DEVELOPMENT GROWTH & DIFFERENTIATION
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis
- (2014) Robert N. Booher et al. PLoS One
- The Role of Cdk5 in Neuroendocrine Thyroid Cancer
- (2013) Karine Pozo et al. CANCER CELL
- Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias
- (2013) Ivana Gojo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting survivin in cancer
- (2012) Dario C. Altieri CANCER LETTERS
- Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network
- (2012) Karl A. Merrick et al. CELL CYCLE
- Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
- (2012) Shu-Fu Lin et al. PLoS One
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
- (2011) Georg Feldmann et al. CANCER BIOLOGY & THERAPY
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells
- (2011) W. Fu et al. MOLECULAR CANCER THERAPEUTICS
- Physiological Relevance of Cell Cycle Kinases
- (2011) Marcos Malumbres PHYSIOLOGICAL REVIEWS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Potential Utility and Limitations of Thyroid Cancer Cell Lines as Models for Studying Thyroid Cancer
- (2009) Tania Pilli et al. THYROID
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
- (2008) Rebecca E. Schweppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development
- (2008) D. O. Cowley et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started